Conferences

ecancer travels so that you don't have to. Explore the latest conference coverage in global oncology and find out where we are going next.
Share :

18th International Meeting of the European Society of Gynaecological Oncology (ESGO)

19 - 22 Oct 2013
Liverpool, United Kingdom of Great Britain and Northern Ireland

Follow up study on the effect of chemotherapy in pregnant women

Prof Fredric Amant - University of Leuven, Belgium
Follow up study on the effect of chemotherapy in pregnant women ( Prof Fredric Amant - University of Leuven, Belgium )
1 Nov 2013

Results from the TRINOVA 1 trial

Prof Bradley Monk - Creighton University School of Medicine, USA
Results from the TRINOVA 1 trial ( Prof Bradley Monk - Creighton University School of Medicine, USA )
1 Nov 2013

Clinical trials, ENGOT and use of bevacizumab against angiogenesis

Prof Christian Marth - Innsbruck Medical University, Austria
Clinical trials, ENGOT and use of bevacizumab against angiogenesis ( Prof Christian Marth - Innsbruck Medical University, Austria )
1 Nov 2013

Emerging sentinel node in cervical cancer

Prof David Cibula - Charles University Hospital, Prague, Czech Republic
Emerging sentinel node in cervical cancer ( Prof David Cibula - Charles University Hospital, Prague, Czech Republic )
1 Nov 2013

Emotional and physical effects of cancer in life after treatment

Prof Annette Hasenburg - Universitätsklinikum Freiburg, Germany
Emotional and physical effects of cancer in life after treatment ( Prof Annette Hasenburg - Universitätsklinikum Freiburg, Germany )
1 Nov 2013

Selecting treatment methods for cervical cancer

Prof Denis Querleu - Claudius Regaud Cancer Center and University of Toulouse, France
Selecting treatment methods for cervical cancer ( Prof Denis Querleu - Claudius Regaud Cancer Center and University of Toulouse, France )
1 Nov 2013

Results of the ICON7, phase III clinical trial

Prof Eric Pujade-Lauraine - Université de Paris Descartes, France
Results of the ICON7, phase III clinical trial ( Prof Eric Pujade-Lauraine - Université de Paris Descartes, France )
1 Nov 2013

Overview of the 2013 ESGO scientific programme

Prof John Green – University of Liverpool, UK
Overview of the 2013 ESGO scientific programme ( Prof John Green – University of Liverpool, UK )
31 Oct 2013

Treatment guidelines for endometrial cancer and increased rates of incidence

Prof John Green - University of Liverpool, UK
Treatment guidelines for endometrial cancer and increased rates of incidence ( Prof John Green - University of Liverpool, UK )
31 Oct 2013

Understanding the causes of endometrial cancer

Prof Martin Widschwendter - University College London Hospital, UK
Understanding the causes of endometrial cancer ( Prof Martin Widschwendter - University College London Hospital, UK )
31 Oct 2013

Disparities in ovarian and cervical cancer screening across Europe

Prof Vesna Kesic - ESGO President Elect
Disparities in ovarian and cervical cancer screening across Europe ( Prof Vesna Kesic - ESGO President Elect )
31 Oct 2013

ESGO president-elect discusses the future goals of the society

Prof Vesna Kesnic - ESGO President Elect
ESGO president-elect discusses the future goals of the society ( Prof Vesna Kesnic - ESGO President Elect )
31 Oct 2013

Fertility preserving surgical treatment methods in young women

Dr Dominik Denschlag - Hoch-Taunus-Hospitals, Germany
Fertility preserving surgical treatment methods in young women ( Dr Dominik Denschlag - Hoch-Taunus-Hospitals, Germany )
31 Oct 2013

Pathologic Ultra Staging in endometrial cancer

Dr Nadeem Abu Rustum - Memorial Sloan Kettering Cancer Center, New York, USA
Pathologic Ultra Staging in endometrial cancer ( Dr Nadeem Abu Rustum - Memorial Sloan Kettering Cancer Center, New York, USA )
31 Oct 2013

End of life care in gynaecological cancer

Dr Johan Menten - University of Lueven, Belgium
End of life care in gynaecological cancer ( Dr Johan Menten - University of Lueven, Belgium )
31 Oct 2013

HPV testing and genotyping in primary screening in developed countries

Dr Mario Sideri
HPV testing and genotyping in primary screening in developed countries ( Dr Mario Sideri )
31 Oct 2013

Molecular profiling of primary compared to metastatic lesion in gynaecologic cancers

Prof Helga Birgitte Salvesen - University of Bergen, Norway
Molecular profiling of primary compared to metastatic lesion in gynaecologic cancers ( Prof Helga Birgitte Salvesen - University of Bergen, Norway )
31 Oct 2013

Outcomes of early stage ovarian endometrioid carcinoma

Dr Aalok Kumar - Medical Oncology, British Columbia Cancer Agency, Vancouver, Canada
Outcomes of early stage ovarian endometrioid carcinoma ( Dr Aalok Kumar - Medical Oncology, British Columbia Cancer Agency, Vancouver, Canada )
1 Oct 2013